Not Yet Recruiting OBSERVATIONAL NCT07448337

Psoriasis Comorbidities at Hospital Calderón Guardia

Prevalence of Metabolic Comorbidities, Atherosclerotic Arterial Disease, and Psoriatic Arthritis in Patients With Psoriasis and Their Association With Clinical Severity and Therapeutic Profile Among Patients Treated at Hospital Rafael Ángel Calderón Guardia During 2024-2025

Sponsor: Caja Costarricense de Seguro Social

Conditions Psoriasis Psoriasis (PsO) Psoriasis Arthritis Psoriasis Patients

Updated 1 time since 2026 Last updated: Mar 2, 2026 Started: May 31, 2026 Primary completion: May 31, 2027 Completion: May 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Psoriasis and Psoriasis (PsO) and is currently actively recruiting participants. Caja Costarricense de Seguro Social leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

1 version recorded

Not Yet Recruiting [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Caja Costarricense de Seguro Social

Data source: Caja Costarricense de Seguro Social

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San José, Costa Rica